Paper18190835
New frontiers in nanotechnology for cancer treatment.
Alexis F and 5 others. Urol Oncol, 2008. Cited by 205 papers, by iCite.
Cite this record
ConductScience Library. New frontiers in nanotechnology for cancer treatment. Papers, record 18190835. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18190835
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nanotechnology | Major topic |
| Urologic Neoplasms | Major topic |
| Dendrimers | |
| Drug Delivery Systems | |
| Drug Design | |
| Humans |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA119349 | NCI NIH HHS | United States | U54CA119349 | PubMed and NIH | NIH RePORTER |
| EB003647 | NIBIB NIH HHS | United States | K08EB003647 | PubMed and NIH | NIH RePORTER |
Cited by87
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 205 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42334650 | Immune-smart nanocarriers for nucleic acid oncology: engineering biomaterials for safe, precise, and durable responses. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42334650 | PubMed |
| 41814097 | Exploring the anticancer potential of epigallocatechin gallate-loaded sodium alginate nanoparticles: impact of size variation on head and neck cancer cells. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/41814097 | PubMed |
| 40837709 | Revolutionizing healthcare: the transformative potential of nanotechnology in medicine. | Front Drug Deliv | 2025 | https://conductscience.org/library/papers/40837709 | PubMed |
| 40808199 | Enhanced Anticancer Activity of Atractylodin-Loaded Poly(lactic-co-glycolic Acid) Nanoparticles Against Cholangiocarcinoma. | Polymers (Basel) | 2025 | https://conductscience.org/library/papers/40808199 | PubMed |
| 39408718 | Nanomedicine in Bladder Cancer Therapy. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39408718 | PubMed |
| 39164280 | Investigation of antibacterial and anticancer activities of copper, aluminum and nickel doped zinc sulfide nanoparticles. | Sci Rep | 2024 | https://conductscience.org/library/papers/39164280 | PubMed |
| 38473773 | Mesoporous Silicon Nanoparticles with Liver-Targeting and pH-Response-Release Function Are Used for Targeted Drug Delivery in Liver Cancer Treatment. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38473773 | PubMed |
| 37747575 | Borophene as an carrier for mercaptopurine drug: electronic study via density-functional theory computations. | J Mol Model | 2023 | https://conductscience.org/library/papers/37747575 | PubMed |
| 37711175 | Dual-targeting peptides@PMO, a mimetic to the pro-apoptotic protein Smac/DIABLO for selective activation of apoptosis in cancer cells. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37711175 | PubMed |
| 37664074 | Research trends and hot spots in global nanotechnology applications in liver cancer: a bibliometric and visual analysis (2000-2022). | Front Oncol | 2023 | https://conductscience.org/library/papers/37664074 | PubMed |
| 37446806 | Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials. | Molecules | 2023 | https://conductscience.org/library/papers/37446806 | PubMed |
| 37376042 | Solid Lipid Nanoparticles vs. Nanostructured Lipid Carriers: A Comparative Review. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37376042 | PubMed |
| 37152471 | Anticancer Evaluation of Methoxy Poly(Ethylene Glycol)-b-Poly(Caprolactone) Polymeric Micelles Encapsulating Fenbendazole and Rapamycin in Ovarian Cancer. | Int J Nanomedicine | 2023 | https://conductscience.org/library/papers/37152471 | PubMed |
| 37125102 | Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities. | ACS Omega | 2023 | https://conductscience.org/library/papers/37125102 | PubMed |
| 37024610 | Toxicity evaluation of silica nanoparticles for delivery applications. | Drug Deliv Transl Res | 2023 | https://conductscience.org/library/papers/37024610 | PubMed |
| 36972480 | Optimizing Conjugation Chemistry, Antibody Conjugation Site, and Surface Density in Antibody-Nanogel Conjugates (ANCs) for Cell-Specific Drug Delivery. | Bioconjug Chem | 2023 | https://conductscience.org/library/papers/36972480 | PubMed |
| 36911792 | A predictive model for personalization of nanotechnology-based phototherapy in cancer treatment. | Front Oncol | 2022 | https://conductscience.org/library/papers/36911792 | PubMed |
| 36145657 | Nano-Formulation Based Intravesical Drug Delivery Systems: An Overview of Versatile Approaches to Improve Urinary Bladder Diseases. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36145657 | PubMed |
| 35646923 | Tumor-Derived Lactate Creates a Favorable Niche for Tumor via Supplying Energy Source for Tumor and Modulating the Tumor Microenvironment. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/35646923 | PubMed |
| 35517745 | Amino acid-modified PAMAM dendritic nanocarriers as effective chemotherapeutic drug vehicles in cancer treatment: a study using zebrafish as a cancer model. | RSC Adv | 2020 | https://conductscience.org/library/papers/35517745 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18190835
GET https://conductscience.org/api/papers/v1/18190835/cited_by?page=2